Drug application
RIBOCICLIB (RIBOCICLIB)
Drugs@FDA ANDA 215677 · ALEMBIC PHARMS LTD
Key facts
| Drug name | RIBOCICLIB |
|---|---|
| Active ingredients | RIBOCICLIB |
| Application type | ANDA |
| Application number | 215677 |
| Company | ALEMBIC PHARMS LTD |
| Dosage forms | TABLET, ORAL |
| Strength | 200MG |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission status date | Jan 10, 2024 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.